Liu Y - Search Results

1

Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.

Li Y, Lee HH, Jiang VC, Che Y, McIntosh J, Jordan A, Vargas J, Zhang T, Yan F, Simmons ME, Wang W, Nie L, Yao Y, Jain P, Wang M, Liu Y. Li Y, et al. Among authors: liu y. Cell Death Dis. 2023 Nov 2;14(11):714. doi: 10.1038/s41419-023-06233-w. Cell Death Dis. 2023. PMID: 37919300 Free PMC article.

2

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.

Zhang L, Yao Y, Zhang S, Liu Y, Guo H, Ahmed M, Bell T, Zhang H, Han G, Lorence E, Badillo M, Zhou S, Sun Y, Di Francesco ME, Feng N, Haun R, Lan R, Mackintosh SG, Mao X, Song X, Zhang J, Pham LV, Lorenzi PL, Marszalek J, Heffernan T, Draetta G, Jones P, Futreal A, Nomie K, Wang L, Wang M. Zhang L, et al. Among authors: liu y. Sci Transl Med. 2019 May 8;11(491):eaau1167. doi: 10.1126/scitranslmed.aau1167. Sci Transl Med. 2019. PMID: 31068440

3

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.

Jain P, Zhao S, Lee HJ, Hill HA, Ok CY, Kanagal-Shamanna R, Hagemeister FB, Fowler N, Fayad L, Yao Y, Liu Y, Moghrabi OB, Navsaria L, Feng L, Nogueras Gonzalez GM, Xu G, Thirumurthi S, Santos D, Iliescu C, Tang G, Medeiros LJ, Vega F, Avellaneda M, Badillo M, Flowers CR, Wang L, Wang ML. Jain P, et al. Among authors: liu y. J Clin Oncol. 2022 Jan 10;40(2):202-212. doi: 10.1200/JCO.21.01797. Epub 2021 Nov 19. J Clin Oncol. 2022. PMID: 34797699 Free PMC article. Clinical Trial.

4

Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.

Li L, Nie L, Jordan A, Cai Q, Liu Y, Li Y, Che Y, Vargas J, Chen Z, Leeming A, Wang W, Yao Y, Wang M, Jiang VC. Li L, et al. Among authors: liu y. Haematologica. 2023 Jun 1;108(6):1616-1627. doi: 10.3324/haematol.2022.281538. Haematologica. 2023. PMID: 36420799 Free PMC article.

5

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma.

Liu Y, Yan F, Jiang VC, Li Y, Che Y, McIntosh J, Jordan A, Hou I, Nie L, Jin J, Wang W, Lee HH, Yao Y, Wang M. Liu Y, et al. Haematologica. 2023 May 1;108(5):1412-1416. doi: 10.3324/haematol.2022.282031. Haematologica. 2023. PMID: 36475521 Free PMC article. No abstract available.

6

Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.

Che Y, Liu Y, Yao Y, Hill HA, Li Y, Cai Q, Yan F, Jain P, Wang W, Rui L, Wang M. Che Y, et al. Among authors: liu y. Blood Cancer J. 2023 Feb 17;13(1):27. doi: 10.1038/s41408-023-00799-6. Blood Cancer J. 2023. PMID: 36797243 Free PMC article.

7

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

Bijou I, Liu Y, Lu D, Chen J, Sloan S, Alinari L, Lonard DM, O'Malley BW, Wang M, Wang J. Bijou I, et al. Among authors: liu y. Res Sq [Preprint]. 2023 Mar 10:rs.3.rs-2653461. doi: 10.21203/rs.3.rs-2653461/v1. Res Sq. 2023. PMID: 36945511 Free PMC article. Updated. Preprint.

8

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma.

Che Y, Liu Y, Li Y, McIntosh JM, Jordan A, Yan F, Wang W, Nie L, Lee HH, Jin J, Yao Y, Zhao Z, Jiang VC, Wang M. Che Y, et al. Among authors: liu y. Blood Adv. 2023 Jul 25;7(14):3361-3365. doi: 10.1182/bloodadvances.2022008954. Blood Adv. 2023. PMID: 37257192 Free PMC article. No abstract available.

9

The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.

Yan F, Jiang V, Jordan A, Che Y, Liu Y, Cai Q, Xue Y, Li Y, McIntosh J, Chen Z, Vargas J, Nie L, Yao Y, Lee HH, Wang W, Bigcal JR, Badillo M, Meena J, Flowers C, Zhou J, Zhao Z, Simon LM, Wang M. Yan F, et al. Among authors: liu y. Exp Hematol Oncol. 2024 Feb 7;13(1):14. doi: 10.1186/s40164-024-00484-9. Exp Hematol Oncol. 2024. PMID: 38326887 Free PMC article.

10

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

Bijou I, Liu Y, Lu D, Chen J, Sloan S, Alinari L, Lonard DM, O'Malley BW, Wang M, Wang J. Bijou I, et al. Among authors: liu y. PLoS One. 2024 Apr 29;19(4):e0289902. doi: 10.1371/journal.pone.0289902. eCollection 2024. PLoS One. 2024. PMID: 38683834 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192,523 results

Search Page